Accretion Nutraveda Limited (BOM:544694)

Accretion Nutraveda Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	160.02	50.05	29.03	5.85
Other Revenue	0.48	0.64	1	-
Revenue	160.49	50.69	30.03	5.85
Revenue Growth (YoY)	216.62%	68.81%	413.23%	-
Cost of Revenue	106.01	28.93	17.34	3.51
Gross Profit	54.48	21.76	12.69	2.34
Selling, General & Admin	6.21	4.2	2.74	1.13
Other Operating Expenses	10.53	4.1	2.45	1.39
Operating Expenses	19.15	10.92	8.3	4.25
Operating Income	35.33	10.85	4.39	-1.91
Interest Expense	-2.78	-2.22	-1.61	-0.81
Interest & Investment Income	0.02	0.69	0.4	0.01
Currency Exchange Gain (Loss)	0.01	-	-	-
Other Non Operating Income (Expenses)	-0.77	-0.18	-0.3	-0.98
Pretax Income	31.81	9.15	2.87	-3.69
Income Tax Expense	5.68	0.93	0.07	0.15
Net Income	26.13	8.22	2.81	-3.84
Net Income to Common	26.13	8.22	2.81	-3.84
Net Income Growth	217.90%	192.91%	-	-
Shares Outstanding (Basic)	4	4	4	359
Shares Outstanding (Diluted)	4	4	4	359
Shares Change (YoY)	0.94%	-	-99.00%	-
EPS (Basic)	7.19	2.28	0.78	-0.01
EPS (Diluted)	7.19	2.28	0.78	-0.01
EPS Growth	215.34%	192.52%	-	-
Free Cash Flow	-30.85	0.72	6.76	-
Free Cash Flow Per Share	-8.49	0.20	1.88	-
Gross Margin	33.95%	42.94%	42.25%	40.05%
Operating Margin	22.02%	21.40%	14.60%	-32.61%
Profit Margin	16.28%	16.21%	9.35%	-65.65%
Free Cash Flow Margin	-19.22%	1.42%	22.51%	-
EBITDA	37.75	13.46	7.5	-0.17
EBITDA Margin	23.52%	26.56%	24.97%	-2.97%
D&A For EBITDA	2.41	2.62	3.11	1.73
EBIT	35.33	10.85	4.39	-1.91
EBIT Margin	22.02%	21.40%	14.60%	-32.61%
Effective Tax Rate	17.85%	10.14%	2.37%	-
Revenue as Reported	160.56	51.97	30.71	5.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.